| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | JUNO THERAPEUTICS INC COM | 122,426 | 7,426,000 | 0.69% | ||
| 52 | RELYPSA INC | 205,000 | 7,394,000 | 0.69% | ||
| 53 | DAVITA INC | 90,000 | 7,315,000 | 0.68% | ||
| 54 | ADVAXIS INC COM NEW | 490,000 | 7,076,000 | 0.66% | ||
| 55 | ZS PHARMA INC | 158,000 | 6,649,000 | 0.62% | ||
| 56 | Wuxi Pharmatech Inc ADR | 168,000 | 6,515,000 | 0.61% | ||
| 57 | Theravance Biopharma Inc | 374,000 | 6,489,000 | 0.61% | ||
| 58 | GW PHARMACEUTICALS PLC | 70,000 | 6,379,000 | 0.60% | ||
| 59 | CONNECTURE INC | 600,000 | 6,210,000 | 0.58% | ||
| 60 | STERIS PLC | 88,000 | 6,184,000 | 0.58% | ||
| 61 | COHERUS BIOSCIENCES INC COM | 199,051 | 6,087,000 | 0.57% | ||
| 62 | NOVAVAX INC COM | 730,000 | 6,037,000 | 0.56% | ||
| 63 | TANDEM DIABETES CARE INC COM | 475,800 | 6,005,000 | 0.56% | ||
| 64 | ACHILLION PHARMACEUTICALS IN | 600,000 | 5,916,000 | 0.55% | ||
| 65 | KYTHERA BIOPHARMACEUTICALS I | 115,000 | 5,767,000 | 0.54% | ||
| 66 | EPIZYME INC COM | 306,500 | 5,756,000 | 0.54% | ||
| 67 | PUMA BIOTECHNOLOGY | 24,250 | 5,726,000 | 0.54% | ||
| 68 | ULTRAGENYX PHARMACEUTICAL INC COM | 92,000 | 5,712,000 | 0.53% | ||
| 69 | WELLCARE HEALTH PLANS INC | 60,000 | 5,488,000 | 0.51% | ||
| 70 | CARDIOME PHARMA CORP | 565,000 | 5,232,000 | 0.49% | ||
| 71 | ALLERGAN PLC | 5,000 | 5,150,000 | 0.48% | ||
| 72 | CERULEAN PHARMA INC | 540,000 | 4,865,000 | 0.46% | ||
| 73 | FIBROGEN INC | 151,300 | 4,748,000 | 0.44% | ||
| 74 | AERIE PHARMACEUTICALS INC COM | 146,000 | 4,576,000 | 0.43% | ||
| 75 | REGENERON PHARMACEUTICALS | 10,000 | 4,515,000 | 0.42% | ||
| 76 | PACIRA PHARMACEUTICALS INC | 50,750 | 4,509,000 | 0.42% | ||
| 77 | JAZZ PHARMACEUTICALS PLC | 26,000 | 4,493,000 | 0.42% | ||
| 78 | ILLUMINA INC | 24,000 | 4,455,000 | 0.42% | ||
| 79 | CERNER CORP | 60,000 | 4,396,000 | 0.41% | ||
| 80 | CHINA CORD BLOOD CORP | 830,000 | 4,241,000 | 0.40% | ||
| 81 | ASSEMBLY BIOSCIENCES INC | 317,500 | 4,204,000 | 0.39% | ||
| 82 | KITE PHARMA INCORPORATED | 71,474 | 4,123,000 | 0.39% | ||
| 83 | CASTLIGHT HEALTH INC COM CL B | 525,000 | 4,074,000 | 0.38% | ||
| 84 | BIOMARIN PHARMACEUTICAL INC | 32,500 | 4,050,000 | 0.38% | ||
| 85 | TETRAPHASE PHARMACEUTICALS INC COM | 102,500 | 3,756,000 | 0.35% | ||
| 86 | MACROGENICS INC | 116,500 | 3,655,000 | 0.34% | ||
| 87 | FIVE PRIME THERAPEUTICS INC | 136,000 | 3,108,000 | 0.29% | ||
| 88 | BLUEBIRD BIO INC COM | 25,000 | 3,019,000 | 0.28% | ||
| 89 | INFINITY PHARMACEUTICALS INC | 215,000 | 3,006,000 | 0.28% | ||
| 90 | AVALANCHE BIOTECHNOLOGIES IN | 70,500 | 2,857,000 | 0.27% | ||
| 91 | BENEFITFOCUS INC | 75,000 | 2,759,000 | 0.26% | ||
| 92 | CELLECTIS S A | 75,000 | 2,594,000 | 0.24% | ||
| 93 | SPARK THERAPEUTICS INCORPORATED | 33,106 | 2,566,000 | 0.24% | ||
| 94 | PTC THERAPEUTICS INC | 40,500 | 2,464,000 | 0.23% | ||
| 95 | XENOPORT INC | 310,000 | 2,207,000 | 0.21% | ||
| 96 | INVITAE CORP | 125,000 | 2,095,000 | 0.20% | ||
| 97 | TRIVASCULAR TECHNOLOGIES INC | 198,000 | 2,077,000 | 0.19% | ||
| 98 | KINDRED BIOSCIENCES INC | 275,000 | 1,964,000 | 0.18% | ||
| 99 | ANTHERA PHARMACEUTICALS I | 425,000 | 1,900,000 | 0.18% | ||
| 100 | RAPTOR PHARMACEUTICAL CORP | 155,000 | 1,685,000 | 0.16% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001184, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
